Introduction:Basic information about CAS 54824-17-8|1H-Benz[de]isoquinoline-1,3(2H)-dione,2-[2-(dimethylamino)ethyl]-5-nitro-, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 1H-Benz[de]isoquinoline-1,3(2H)-dione,2-[2-(dimethylamino)ethyl]-5-nitro- |
|---|
| CAS Number | 54824-17-8 | Molecular Weight | 313.30800 |
|---|
| Density | 1.384g/cm3 | Boiling Point | 496.8ºC at 760 mmHg |
|---|
| Molecular Formula | C16H15N3O4 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 254.3ºC |
|---|
Names
| Name | 2-[2-(dimethylamino)ethyl]-5-nitrobenzo[de]isoquinoline-1,3-dione |
|---|
| Synonym | More Synonyms |
|---|
BiologicalActivity
| Description | Mitonafide (NSC 300288) is a cytostatic agent. Mitonafide binds to double-stranded DNA through intercalation, and inhibits DNA and RNA synthesis. Mitonafide is an antitumor agent that can be used in the research of cancers, such as non-small cell lung cancer (NSCLC), leukemia[1][2][3]. |
|---|
| Related Catalog | Research Areas >>CancerSignaling Pathways >>Cell Cycle/DNA Damage >>DNA/RNA Synthesis |
|---|
| Target | DNA and RNA synthesis[1] |
|---|
| In Vitro | Mitonafide inhibits DNA and RNA synthesis and induces single-strand breaks in the DNA of chinese hamster ovary cells[1]. The incubation of Mitonafide with rat liver microsomes and NADPH under anaerobic conditions results in the formation of a metabolite identified as 5-aminomitonafide[2]. Mitonafide (25, 50 μM, 1 h) induces single-stand breaks in the DNA of L1210 cells[2]. Mitonafide (10-100 μM) exhibits cytotoxic effect in the HOP-62 lung cell line[4]. Cell Viability Assay[6] Cell Line: SK-OV-3, HepG2, A-549, T-24, SMMC-7721, HL-7702 Concentration: 0-100 μM respectively. Incubation Time: 48 h Result: Inhibited cell viability with IC50 values of 6.26, 10.88, 7.94, 5.01, 6.94, 8.51 μM. |
|---|
| In Vivo | Mitonafide (0.5 and 1 mg/kg, i.p., 1-7 days) shows antitumoral potency in S-180 bearing mice[4]. Mitonafide (5 mg/kg, i.p., twice a day) shows anticancer activity in HepG2 xenograft model[6]. Mitonafide (single i.p. injection, S-180 bearing mice) shows the LD50 value of 10.0 mg/kg[5]. Animal Model: S-180 bearing mice[4] Dosage: 0.5 mg/kg and 1 mg/kg Administration: Intraperitoneal injection (i.p.) for 1-7 days Result: Increased in median survival times. Animal Model: HepG2 xenograft model [6] Dosage: 5 mg/kg Administration: Intraperitoneal injection (i.p.), twice a day. Result: Exhibited a relative tumor increment rates (T/C) value of 28.8%. |
|---|
| References | [1]. Llombart M, et al. Phase I study of mitonafide in solid tumors. Invest New Drugs. 1992 Aug;10(3):177-81. [2]. inha BK, et al. Mechanism of DNA strand breaks by mitonafide, an imide derivative of 3-nitro-1,8-naphthalic acid. Biochem Pharmacol. 1985 Nov 1;34(21):3845-52. [3]. Rosell R, et al. Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer. Invest New Drugs. 1992 Aug;10(3):171-5. [4]. Samanta S, et al. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent. J Exp Ther Oncol. 2005;5(1):15-22. [5]. Pain A, et al. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent. J Exp Clin Cancer Res. 2003 Sep;22(3):411-8. [6]. Xin M, et al. Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agents. Bioorg Med Chem Lett. 2020 Apr 15;30(8):127051. |
|---|
Chemical & Physical Properties
| Density | 1.384g/cm3 |
|---|
| Boiling Point | 496.8ºC at 760 mmHg |
|---|
| Molecular Formula | C16H15N3O4 |
|---|
| Molecular Weight | 313.30800 |
|---|
| Flash Point | 254.3ºC |
|---|
| Exact Mass | 313.10600 |
|---|
| PSA | 88.13000 |
|---|
| LogP | 1.94570 |
|---|
| Index of Refraction | 1.667 |
|---|
| InChIKey | XXVLKDRPHSFIIB-UHFFFAOYSA-N |
|---|
| SMILES | CN(C)CCN1C(=O)c2cccc3cc([N+](=O)[O-])cc(c23)C1=O |
|---|
| Storage condition | 2-8°C |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- QK5650000
- CHEMICAL NAME :
- Naphthalimide, 2-(2-(dimethylamino)ethyl)-5-nitro-
- CAS REGISTRY NUMBER :
- 54824-17-8
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 6
- MOLECULAR FORMULA :
- C16-H15-N3-O4
- MOLECULAR WEIGHT :
- 313.34
- WISWESSER LINE NOTATION :
- T666 1A M CVNVJ D2N1&1 HNW
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 6500 ug/kg
- TOXIC EFFECTS :
- Tumorigenic - active as anti-cancer agent
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 10000 ug/kg
- TOXIC EFFECTS :
- Tumorigenic - active as anti-cancer agent
MUTATION DATA - TYPE OF TEST :
- Mutation test systems - not otherwise specified
- TEST SYSTEM :
- Rodent - mouse Ascites tumor
- DOSE/DURATION :
- 4 mg/L
- REFERENCE :
- CCPHDZ Cancer Chemotherapy and Pharmacology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1978- Volume(issue)/page/year: 4,61,1980
|
Safety Information
Customs
| HS Code | 2933990090 |
|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|---|
Synonyms
| 2-(2-(dimethylamino)ethyl)-3-nitro-1H-benzo[de]isoquinoline-1,3(2H)-dione |
| Mitonafidum [INN-Latin] |
| Mitonafida [INN-Spanish] |
| M 4212 (Pharmaceutical) |
| 2-(2-(dimethylamino) ethyl)-5-nitro-1H-benzo[de]isoquinoline-1,3(2H)-dione |
| N-(2-(Dimethylamino)ethyl)-3-nitronaphthalimide |
| M-4212 |
| 2-(2-dimethylaminoethyl)-5-nitrobenzo[de]isoquinoline-1,3-dione |
| Mitonafide |